The warning comes amid reports that unregulated therapies are being offered directly to patients, potentially illegally. View ...

After Brexit, over 12,000 centrally-authorised MAs for medicines ... preserve a close tie between the UK and the European regulator the European Medicines Agency (EMA), but EU27 politicians ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

Our industry’s ability to reliably provide medicines to patients across Europe came into sharp focus during the early stages of the COVID-19 crisis. Almost overnight, borders closed, export ...

The European Commission’s long-promised revamp ... between being pro innovation and supporting patient access to authorised medicines. These proposals seek to maintain that balance, but industry ...

The EU executive included a new 'Buy Europe' mechanism with its long-awaited proposal for a Critical Medicines Act, unveiled on Tuesday, a key piece of health legislation for this term.

Donald Trump’s return to the White House and his announcement of future 25% tariffs on various sectors, including the pharmaceutical industry, prompted the Commission to revive the concept of ...

Europe is gearing up for a future where it can stand on its own, and health care is no exception. The Covid-19 pandemic exposed weaknesses in the EU’s medicines markets – vulnerable supply chains for ...

The agency advises patients to confirm that any cell, gene, or tissue therapy they receive is approved by a regulator or authorized for use in a clinical trial.